Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,008 public trials 572 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis

NCT01222260

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Tufts Medical Center Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Mt. Sinai Medical Center New York, United States
View Trial Details
Completed

Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma

NCT01023308

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Anaheim, California, United States
  • Novartis Investigative Site Concord, California, United States
  • Novartis Investigative Site Los Angeles, California, United States
View all 210 locations
View Trial Details
Completed

Study of Ibrutinib in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed/Relapsed and Refractory Multiple Myeloma

NCT02902965

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Fakultní nemocnice Brno Brno, Czechia
  • Fakultní nemocnice Hradec Králové Nový Hradec Králové, Czechia
  • Fakultní nemocnice Ostrava Ostrava-Poruba, Czechia
  • Všeobecná fakultní nemocnice v Praha Prague, Czechia
View all 33 locations
View Trial Details
Completed

A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers

NCT01587703

Conditions
Blood Protein Disorders, Bronchial Neoplasms, Carcinoma, +31 more
Locations
  • GSK Investigational Site Baltimore, Maryland, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
  • GSK Investigational Site Nashville, Tennessee, United States
View all 17 locations
View Trial Details
Completed

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma

NCT00918333

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +75 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mark O Hatfield-Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma

NCT01478581

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • SITE-13 La Jolla, California, United States
  • SITE-5 Baltimore, Maryland, United States
  • SITE-4 Boston, Massachusetts, United States
  • SITE-8 Ann Arbor, Michigan, United States
View Trial Details

Related conditions